Inhalation of tobramycin in cystic fibrosis Part 2: Optimization of the tobramycin solution for a jet and an ultrasonic nebulizer

International Journal of Pharmaceutics

Volumn 189, Issue 2, 1999, Pages 215-225

  Le Brun, P P H ^a   De Boer, A H ^b   Gjaltema, D ^b   Hagedoorn, P ^b   Heijerman, H G M ^c   Frijlink, H W ^b  

^a Central Hospital Pharmacy   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c LEYENBURG HOSPITAL   (Netherlands)

Author keywords

Cascade impactor; Cystic fibrosis; Inhalation; Laser diffraction; Nebulizer; Tobramycin

Indexed keywords

TOBRAMYCIN; WATER;

AEROSOL; APPARATUS; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG FORMULATION; DRUG SOLUTION; INHALATION; INTERMETHOD COMPARISON; LASER DIFFRACTION; NEBULIZATION; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL; ULTRASOUND;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; KINETICS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PRESSURE; SOLUTIONS; TOBRAMYCIN; ULTRASONICS;

EID: 0032819518     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00252-5     Document Type: Article

References (17)

1. Coates A.L., MacNeish C.F., Meisner D., Keleman S., Thibert R., MacDonald J., Vadas E. The choice of jet nebulizer, nebulizing flow and addition of albuterol affects the output of tobramycin aerosols. Chest. 111:1997;1206-1212.
2. Davis P.B., Drumm M., Konstan M.W. Cystic fibrosis. Am. J. Respir. Crit Care Med. 154:1996;1229-1256.
3. Hurley P.K., Smye S.W., Cunliffe H. Assessment of antibiotic aerosol generation using commercial jet nebulizers. J. Aerosol Med. 7:1994;217-228.
4. Laube B.L. Measurement of aerosol deposition in CF. Pediatr. Pulm. 21(Suppl 17):1998;181-182.
5. Le Brun, P.P.H., De Boer, A.H., Gjaltema, D., Hagedoorn, P., Heijerman, H.G.M., Frijlink, H.W., 1999a. Inhalation of tobramycin in cystic fibrosis. Part 1: The choice of a nebulizer. Int. J. Pharm., in press.
6. Le Brun, P.P.H., Vinks, A.A.T.M.M. Vinks, Touw, D.J., Hekelaar, N., Mannes, G.P.M., Brimicombe, W., Frijlink, H.W., Heijerman, H.G.M., 1999b. Improvement of tobramycin inhalation with a jet nebulizer; a pharmacokinetic analysis. Ther. Drug Mon., in press.
7. McCallion O.N.M., Taylor K.M.G., Bridges P.A., Thomas M., Taylor A.J. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm. Res. 12:1995;1682-1688.
8. McCallion O.N.M., Taylor K.M.G., Thomas M., Taylor A.J. The influence of surface tension on aerosols produced by medical nebulisers. Int. J. Pharm. 129:1996a;123-136.
9. McCallion O.N.M., Taylor K.M.G., Bridges P.A., Thomas M., Taylor A.J. Jet nebulizers for pulmonary delivery. Int. J. Pharm. 130:1996b;1-11.
10. Mukhopadhyay S., Singh M., Cater J.I., Ogston S., Franklin M., Olver R.E. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax. 51:1996;364-368.
11. Newman S.P., Clarke S.W. Therapeutic aerosols. 1. Physical and practical considerations. Thorax. 38:1983;881-886.
12. O'Callaghan C., Barry P.W. The science of nebulised drug delivery. Thorax. 52(Suppl. 2):1997;S31-S44.
13. Ramsey B.W., Pepe M.S., Quan J.M., Kelly L.O., Monygomery A.B., Williams-Warren J., Vasiljev-K M., Borowitz D., Bowman C.M., Marshall S., Smith A.L. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N. Engl. J. Med. 340:1999;23-30.
14. Touw D.J., Brimicombe R.W., Hodson M.E., Heijerman H.G.M., Bakker W. Inhalation of antibiotics in cystic fibrosis. Eur. Respir. J. 8:1995;1594-1604.
15. Touw D.J., Jacobs F.A.H., Brimicombe R.W., Heijerman H.G.M., Bakker W., Breimer D.D. Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis. Antimicrob. Agents Chemother. 41:1997;184-187.
16. Webb A.K., Dodd M.E. Nebulized antibiotics for adults with cystic fibrosis. Thorax. 52(Suppl. 2):1997;S69-S71.
17. Weber A., Morlin G., Cohen M., Williams-Warren J., Ramsey B., Smith A. Effect of nebulizer type and antibiotic concentration on device performance. Pediatr. Pulmonol. 23:1997;249-261.